Heraeus has acquired Biomain to enhance its position in the Northern European dental technology market, leveraging Biomain's expertise in CAD/CAM-based prosthetics.
Target Company Overview
On March 1, 2012, Heraeus, a leading global supplier of materials and solutions for computer-aided design (CAD) and computer-aided manufacturing (CAM) aimed at dental professionals, announced the completion of its acquisition of Biomain, a prominent company based in Sweden. Biomain is recognized as the market leader in Scandinavia for customized CAD and CAM-based implant-borne prosthetics. This acquisition allows Heraeus to enhance its innovative offerings in dental technology.
Biomain's established reputation in implant technology and its strong market presence make it a strategic fit for Heraeus. By integrating Biomain’s expertise, Heraeus aims to enhance its product portfolio while further solidifying its position in the Nordic markets for dental solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Sweden
The dental technology industry in Sweden has been characterized by significant innovation and a strong focus on research and development. Sweden is home to numerous companies that specialize in high-quality dental materials and pr
Similar Deals
Swedish Orphan Biovitrum AB (Sobi) → Arthrosi Therapeutics, Inc.
2025
Heraeus
invested in
Biomain
in 2012
in a Merger deal